Arctic Bioscience AS Company Description

Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds.

The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis.

It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand worldwide.

The company was incorporated in 2011 and is headquartered in Ørsta, Norway.

Arctic Bioscience AS

Country	Norway
Founded	2011
Industry	Biotechnology
Sector	Healthcare
Employees	355
CEO	Christer Valderhaug

Contact Details

Address: Industrivegen 42 Ørsta, 6155 Norway
Phone	47 95 29 33 84
Website	arctic-bioscience.com

Stock Details

Ticker Symbol	ABS
Exchange	Oslo Børs
Fiscal Year	January - December
Reporting Currency	NOK
ISIN Number	NO0010859580
SIC Code	2836

Key Executives

Name	Position
Christer L. Valderhaug	Chief Executive Officer
Harald Nordal M.B.A., M.Sc., MBA, MSc	Co-Founder and Chairman
Hogne Hallaraker	Founder and Chief Scientific Officer
Jone R. Slinning	Chief Financial Officer
Per Christian Sæbo	Chief Operating Officer
Daniele Mancinelli	Chief Technical Officer
Steffen Erland Eidal	Senior Vice President of Sales and Marketing
Dr. Yuming Feng	Executive Vice President of Global Business Development
Dr. Runhild Gammelsæter	Global Medical Director